Tyrosine kinase inhibitors

Details for Australian Patent Application No. 2003230835 (hide)

Owner MERCK AND CO., INC.

Inventors Kim, Annette; Trotter, B Wesley; Dinsmore, Christopher J; Williams, Theresa M; Nguyen, Diem N; Graham, Samuel L; Stump, Craig A

Agent Spruson & Ferguson

Pub. Number AU-A-2003230835

PCT Number PCT/US03/10737

PCT Pub. Number WO2003/086395

Priority 60/372,644 12.04.02 US

Filing date 8 April 2003

Wipo publication date 27 October 2003

International Classifications

A61K 031/439 - the ring forming part of a bridged ring system, e.g. quinuclidine

C07D 221/22 Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups

A61P 035/00 Antineoplastic agents

Event Publications

14 August 2003 Complete Application Filed

  Priority application(s): 60/372,644 12.04.02 US

4 December 2003 Application Open to Public Inspection

  Published as AU-A-2003230835

6 November 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003230836-Compounds and methods for inducing apoptosis in proliferating cells

2003230834-ANTAGONISTS OF IL-21 AND MODULATION OF IL-21-MEDIATED T CELL RESPONSES